Fibrose pulmonaire : quand les regards convergent

A collaborative discussion, informed by a macro-level, inspiring, and human-centered approach, on the future of pulmonary fibrosis care, featuring: Professor Cottin: pulmonologist and coordinator of the National Reference Center for Rare Lung Diseases in Lyon Jean-Michel Fourrier, patient and president of the French Pulmonary Fibrosis Association (AFPF) Boehringer Ingelheim, a pharmaceutical company committed to all stages of the care pathway Three aligned perspectives—practice, experience, and research—highlight that advancing the management of this disease requires a collective commitment.